Skip to content

Author

Mahsa Hasannejad Alibaglou

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Dendrimer-Based Nanoplatforms for Cancer Diagnosis and Therapy: from Liquid Biopsy to Targeted Protein Degradation

Dendrimer-based systems have shown considerable potential to remodel the tumor microenvironment, induce immunogenic cell death, enhance immune activation, and facilitate combination therapies, offering promising opportunities to improve cancer diagnosis, treatment, and patient outcomes.

Mahsa Hasannejad Alibaglou, Zeinab Chaharlashkar, Fateme Bina et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.